Ernexa Therapeutics Inc. - ERNA
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$749K
QoQ value delta ($000)
+$126K
(+20.22%)
Implied price effect (QoQ)
-82.59%
Shares
Total shares
3,610,281
QoQ shares delta
+3,087,583
(+590.7%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (ERNA)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 20 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Bleichroeder LP | 398 | 2,000,000 | 0.07% |
| Dauntless Investment Group, LLC | 121 | 612,443 | 0.08% |
| Corient Private Wealth LLC | 87 | 438,093 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 48 | 244,446 | 0.0% |
| VANGUARD GROUP INC | 43 | 35,922 | 0.0% |
| Warberg Asset Management LLC | 10 | 50,000 | 0.0% |
| XTX Topco Ltd | 10 | 54,338 | 0.0% |
| JANE STREET GROUP, LLC | 8 | 41,167 | 0.0% |
| CITADEL ADVISORS LLC | 6 | 33,076 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 5 | 25,447 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5 | 26,504 | 0.0% |
| UBS Group AG | 4 | 21,233 | 0.0% |
| GOLDMAN SACHS GROUP INC | 3 | 16,631 | 0.0% |
| Sippican Capital Advisors | 1 | 10,000 | 0.0% |
| MONTAG A & ASSOCIATES INC | 0 | 8 | 0.0% |
| BNP PARIBAS FINANCIAL MARKETS | 0 | 10 | 0.0% |
| ASSETMARK, INC | 0 | 133 | 0.0% |
| Activest Wealth Management | 0 | 3 | 0.0% |
| BlackRock, Inc. | 0 | 820 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 6 | 0.0% |
| Caitong International Asset Management Co., Ltd | 0 | 1 | 0.0% |